AlphAIalphai — Financial news for AI agents
TrefisAPR 84 min read$PLSE

How Low Can PLSE Really Go In A Market Crash?

This article analyzes Pulse Biosciences (PLSE) stock's performance during past market crashes to assess its risk profile. It reveals that PLSE has averaged a -34% contraction during eight major market dislocations, significantly underperforming the S&P 500's -15% drop. The analysis details PLSE's drawdowns during specific events like the 2022 Fed Tightening Inflation Bear Market (-92%) and the 2025 US Tariff Shock (-29%), concluding that such steep contractions are a baseline expectation for the stock during market shocks.

Original reporting
Trefis · Trefis Team
Published Apr 8, 2026, 4:52 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Apr 8, 2026, 5:30 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
How Low Can PLSE Really Go In A Market Crash? — source image
Source · Trefis
Decision brief

The 30-second read

$PLSEBearishLow
01

Why it matters

The historical data suggests that PLSE is highly susceptible to market shocks, with potential for substantial declines, which should inform risk management strategies.

02

Market read

The biotech sector is sensitive to macroeconomic shocks, and PLSE's historical performance indicates high vulnerability during market downturns.

03

What to watch

Company-specific developments, such as new product approvals or partnerships, could offset sector-wide declines and influence PLSE's recovery trajectory.

Timing: Long-term

Background

This article analyzes historical performance of PLSE during past market crashes to assess its risk profile, revealing significant average drawdowns.

Company-level read

Ticker impact

$PLSEBearishMedium confidence
Context

High relevance due to direct focus on Pulse Biosciences (PLSE) stock and its historical performance during market crashes.

Expected impact

Potential for a decline of approximately 30-40% in a severe market crash, aligning with historical average drawdowns.

Evidence & confidence

Based on historical performance during past crashes, PLSE has shown considerable vulnerability. However, future declines depend on the nature of the market shock and company-specific factors, which are uncertain.

Market effects

Sector

The biotech sector may experience heightened volatility during market crashes, impacting PLSE and similar stocks.

Regional

US markets are likely to see increased declines, affecting biotech stocks like PLSE.

Global

Limited; PLSE's performance is primarily influenced by US market conditions and sector-specific factors.

Counterpoint

What could challenge this read

PLSE's innovative therapies could lead to resilience and quicker recovery post-crash, making it a potential contrarian buy during downturns.

Key entities

  • Company
    Pulse Biosciences

    A biotech company specializing in bioelectric medicine and cell-based therapies.

Read at source← All news

Related articles

AUG 6
$PLSEMed

PULSE BIOSCIENCES, INC. (PLSE): Results of Operations and Financial Condition

PULSE BIOSCIENCES, INC. (PLSE) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex_964658.htm PRESS RELEASE ISSUED BY PULSE BIOSCIENCES, INC. DATED AUGUST 6, 2026 - BUSINESS UPDATES AND FINANCIAL RESULTS ex_964658.htm Exhibit 99.1 Pulse Biosciences Reports Business Updates and Second Quarter 2026 Financial Results HAYWARD, California [Business Wire

SEC EDGAR 8-K7 min
AUG 8
$ACIMed

Albertsons recalls ready-to-eat items in multiple states amid salmonella-linked jalapeño investigation

Albertsons Companies said it is voluntarily recalling four ready-to-eat products containing jalapeños supplied by Taylor Farms, including items sold at Randalls in Texas. The recall followed a supplier recall tied to an ongoing federal investigation and an FDA probe of a Salmonella Javiana outbreak. FDA reported 345 illnesses in 27 states, 36 hospitalizations, no deaths.

click2houston.com5 min
AUG 8
$CMGMed

Salmonella outbreak from Mexican jalapeños reported in 27 U.S. states

U.S. health authorities are investigating a Salmonella outbreak linked to Mexican jalapeño peppers. The CDC and FDA say 345 people are ill across 27 states, with 36 hospitalizations and no deaths. The supplier, Coast Citrus Distributors, recalled peppers sent to restaurants including Chipotle and QDOBA. Chipotle removed jalapeños from some outlets and shares fell over 8% on Aug. 4.

2lt.com.au4 min
AUG 8
$RKLBMedAI 8/10

Rocket Lab Just Unveiled a Game-Changing Technology Worth Watching

Rocket Lab (RKLB) said it won a $397 million U.S. Space Force contract to develop, launch, and operate multiple Flatellites for the SB-AMTI program. Flatellites are slimmer, stackable satellites intended to increase deployments per launch and integrate with Rocket Lab’s Neutron rocket. The article cites analyst forecasts for revenue rising from $602M (2025) to $1.7B (2028).

fool.com6 min